2025
Nasopharyngeal Carriage, Antimicrobial Resistance, and Serotype Distribution of Streptococcus pneumoniae in Children Under Five in Lebanon: Baseline Data Prior to PCV13 Introduction
Rafei R, Zaylaa M, Diab M, Kassem I, Omari K, Halimeh F, Moujaber G, Achour A, Ismail B, Mallat H, Hamze M, Dabboussi F, Osman M. Nasopharyngeal Carriage, Antimicrobial Resistance, and Serotype Distribution of Streptococcus pneumoniae in Children Under Five in Lebanon: Baseline Data Prior to PCV13 Introduction. Antibiotics 2025, 14: 168. PMID: 40001412, PMCID: PMC11851980, DOI: 10.3390/antibiotics14020168.Peer-Reviewed Original ResearchPneumococcal conjugate vaccineCarriage of pneumococciNasopharyngeal carriageSerotype distribution of Streptococcus pneumoniaePCV13 vaccination coverageAntimicrobial susceptibility testingAntimicrobial-resistance profilesLevels of antibiotic resistanceInvasive pneumococcal diseaseStreptococcus pneumoniae</i>Pneumococcal conjugate vaccine vaccinationNew vaccine developmentPneumococci isolatesPCV13 introductionTrimethoprim-sulfamethoxazoleCarriage serotypesVaccine serotypesSerotype distributionSusceptibility testingAntimicrobial-resistantPositive culturesInvasive diseaseMultidrug resistancePneumococcal diseaseSource of transmission
2024
An unusual case of primary melioidotic prostatic disease: Misdiagnosed as benign prostatic hyperplasia
Cai Y, Jiang H, Li T, Luo D, Li P, Wang Y. An unusual case of primary melioidotic prostatic disease: Misdiagnosed as benign prostatic hyperplasia. Heliyon 2024, 10: e37906. PMID: 39323819, PMCID: PMC11422042, DOI: 10.1016/j.heliyon.2024.e37906.Peer-Reviewed Original ResearchBenign prostatic hyperplasiaProstate diseaseProstatic hyperplasiaBurkholderia pseudomallei</i>.Urine culturePulmonary infectionTrimethoprim-sulfamethoxazoleSurvival rate of patientsTreated with imipenemUrinary tract infectionAnti-infective treatmentRate of patientsHistory of hypertensionYear old maleMultiple organ damageProstatic abscessTract infectionsInflammatory markersClinical manifestationsCure rateUnusual caseFatal infectious diseaseOrgan damageDifficulty urinatingSurvival rate
2023
Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation
Trubin P, Azar M. Current Concepts in the Diagnosis and Management of Pneumocystis Pneumonia in Solid Organ Transplantation. Infectious Disease Clinics Of North America 2023, 37: 617-640. PMID: 37142510, DOI: 10.1016/j.idc.2023.03.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsSolid organ transplant recipientsOrgan transplant recipientsFirst-choice agentsSolid organ transplantationAppropriate clinical contextTransplant recipientsInterstitial pneumoniaTrimethoprim-sulfamethoxazoleOptimal treatmentPneumocystis pneumoniaOrgan transplantationInfection manifestsPrevention strategiesNucleic acid amplificationDiagnostic testingRadiographic imagingTissue samplingClinical contextLung fluidCurrent conceptsHost susceptibilityPneumoniaAcid amplificationTreatmentProphylaxisArtemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Nyangulu W, Mungwira R, Divala T, Nampota-Nkomba N, Nyirenda O, Buchwald A, Miller J, Earland D, Adams M, Plowe C, Taylor T, Mallewa J, van Oosterhout J, Parikh S, Laurens M, Laufer M. Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi. Malaria Journal 2023, 22: 32. PMID: 36707795, PMCID: PMC9881508, DOI: 10.1186/s12936-023-04466-w.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyLumefantrine levelsTreatment failureDrug-drug interactionsACPR ratesMalaria infectionTrimethoprim-sulfamethoxazolePCR correctionTreatment efficacyUndetectable HIV RNA viral loadEfavirenz-based antiretroviral therapyHIV RNA viral loadUncomplicated Plasmodium falciparum malariaHuman immunodeficiency virus (HIV) infectionArtemether-lumefantrine efficacyCohort of PWHEfavirenz-based regimensImmunodeficiency virus infectionRNA viral loadPlasmodium falciparum malariaMalaria treatment failurePopulation of adultsRandom-effects modelTherapeutic efficacy monitoringLumefantrine exposureRisk factors for serious infections in ANCA-associated vasculitis
Odler B, Riedl R, Gauckler P, Shin J, Leierer J, Merkel P, St. Clair W, Fervenza F, Geetha D, Monach P, Jayne D, Smith R, Rosenkranz A, Specks U, Stone J, Kronbichler A, Group R. Risk factors for serious infections in ANCA-associated vasculitis. Annals Of The Rheumatic Diseases 2023, 82: 681-687. PMID: 36702528, PMCID: PMC10176387, DOI: 10.1136/ard-2022-223401.Peer-Reviewed Original ResearchConceptsAntineutrophil cytoplasmic antibody-associated vasculitisRisk of severe infectionANCA-associated vasculitisSevere infectionsLaboratory data of patientsRisk factorsCD19+ cellsAntibody-associated vasculitisPneumocystis jirovecii</i>Associated with reduced riskAssociated with lower riskB cell subpopulationsRespiratory tract infectionsCox regression analysisSerum immunoglobulin M levelsData of patientsCox regression modelsImmunoglobulin M levelsRAVE trialTrimethoprim-sulfamethoxazoleTract infectionsCD3+T cellsRituximabTrial entryDecreased risk
2019
First data on antimicrobial susceptibility patterns of Moraxella catarrhalis isolates in Lebanon
Hamze M, Osman M, Mallat H, Achkar M. First data on antimicrobial susceptibility patterns of Moraxella catarrhalis isolates in Lebanon. The International Arabic Journal Of Antimicrobial Agents 2019, 9 DOI: 10.3823/833.Peer-Reviewed Original ResearchAntimicrobial susceptibility patternsMoraxella catarrhalisSusceptibility patternsM. catarrhalisM. catarrhalis strainsAntibiotic susceptibility ratesEffective empirical treatmentThroats of patientsAntimicrobial susceptibility profilesEmergence of resistanceAntimicrobial susceptibility testingMajority of antibioticsReliable diagnostic toolNini HospitalTrimethoprim-sulfamethoxazoleAppropriate treatmentEmpirical treatmentSusceptibility ratesAntibiotic susceptibilityClinical specimensCatarrhalisPercent susceptibilityClinical settingSusceptibility testingSusceptibility profiles
2012
Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature
Knoll B, Hammond S, Koo S, Issa N, Tullius S, Baden L, Pomahac B, Marty F. Infections Following Facial Composite Tissue Allotransplantation—Single Center Experience and Review of the Literature. American Journal Of Transplantation 2012, 13: 770-779. PMID: 23279299, DOI: 10.1111/ajt.12013.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Infective AgentsCatheter-Related InfectionsCytomegalovirusCytomegalovirus InfectionsFaceFemaleGraft RejectionGraft SurvivalHumansMaleMiddle AgedPneumoniaPostoperative ComplicationsPrognosisSurgical Wound InfectionTissue TransplantationTransplantation, HomologousTrimethoprim, Sulfamethoxazole Drug CombinationConceptsFacial composite tissue allotransplantationCMV diseaseInfectious complicationsPosttransplant infectionsClostridium difficile-associated diarrheaDiscontinuation of prophylaxisEarly posttransplant infectionsSurgical site infectionDifficile-associated diarrheaCatheter-associated infectionsComposite tissue allotransplantationInvasive dermatophyte infectionAdditional prophylaxisBacterial parotitisPerioperative prophylaxisValganciclovir treatmentCenter experienceProphylaxis strategiesSite infectionPolymicrobial bacteremiaRecipient factorsTrimethoprim-sulfamethoxazoleMedical recordsDermatophyte infectionsProphylaxis
2009
Antimicrobial Susceptibility of Bacteria Isolated from Urine Samples Obtained from Nursing Home Residents
Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M. Antimicrobial Susceptibility of Bacteria Isolated from Urine Samples Obtained from Nursing Home Residents. Infection Control And Hospital Epidemiology 2009, 30: 1116-1119. PMID: 19785518, PMCID: PMC2866029, DOI: 10.1086/647981.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overAnti-Bacterial AgentsDrug Resistance, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsEscherichia coliEscherichia coli InfectionsFemaleHomes for the AgedHumansMaleMicrobial Sensitivity TestsNitrofurantoinNursing HomesTrimethoprim, Sulfamethoxazole Drug CombinationUrinary Tract InfectionsUrineConceptsUrinary tract infectionNursing home residentsTract infectionsHome residentsUrine samplesEmpiric antimicrobial therapyOral antibioticsAntibiotic therapyIndwelling catheterTrimethoprim-sulfamethoxazoleAntimicrobial therapyResistance patternsAntimicrobial susceptibilityPredominant organismTherapyInfectionResidentsCatheterNitrofurantoin
2002
Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines
Goldie SJ, Kaplan JE, Losina E, Weinstein MC, Paltiel AD, Seage GR, Craven DE, Kimmel AD, Zhang H, Cohen CJ, Freedberg KA. Prophylaxis for Human Immunodeficiency Virus–Related Pneumocystis carinii Pneumonia: Using Simulation Modeling to Inform Clinical Guidelines. JAMA Internal Medicine 2002, 162: 921-928. PMID: 11966344, DOI: 10.1001/archinte.162.8.921.Peer-Reviewed Original ResearchMeSH KeywordsAIDS-Related Opportunistic InfectionsAnti-Infective AgentsAntiprotozoal AgentsAtovaquoneCD4 Lymphocyte CountCost-Benefit AnalysisDapsoneDrug CostsHumansLife ExpectancyModels, TheoreticalNaphthoquinonesPentamidinePneumonia, PneumocystisPractice Guidelines as TopicQuality-Adjusted Life YearsConceptsQuality-adjusted life yearsCD4 cell countQuality-adjusted life expectancyPneumocystis carinii pneumoniaCD4 cell count increasePCP prophylaxisCell count increaseCell countCarinii pneumoniaClinical guidelinesCD4 cell count criteriaInitial CD4 cell countCD4 lymphocyte countPrimary PCP prophylaxisActive antiretroviral therapyCohort of HIVHuman immunodeficiency virusTMP/SMXCount increaseAntiretroviral therapyLymphocyte countHIV infectionImmunodeficiency virusTrimethoprim-sulfamethoxazoleProphylaxis
1996
Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
Perazella M, Mahnensmith R. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose. Clinical Nephrology 1996, 46: 187-92. PMID: 8879854.Peer-Reviewed Original ResearchConceptsTrimethoprim-sulfamethoxazole therapyStandard doseDevelopment of hyperkalemiaTrimethoprim-sulfamethoxazole useMild renal insufficiencyProspective surveillance studyPotassium-sparing diuretic amilorideRenal potassium excretionPneumocystis carinii pneumoniaLethal adverse reactionHandful of casesRenal insufficiencyElderly patientsPotassium excretionSevere hyperkalemiaImportant complicationAIDS patientsCarinii pneumoniaTrimethoprim-sulfamethoxazoleAdverse reactionsInduced hyperkalemiaPotassium disordersHyperkalemiaSurveillance studyPatientsHyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
Alappan R, Perazella M, Buller G. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole. Annals Of Internal Medicine 1996, 124: 316-20. PMID: 8554227, DOI: 10.7326/0003-4819-124-3-199602010-00006.Peer-Reviewed Original ResearchConceptsSerum potassium concentrationSerum creatinine levelsMumol/LBlood urea nitrogen levelsPeak potassium concentrationTrimethoprim-sulfamethoxazole therapyCreatinine levelsUrea nitrogen levelsTrimethoprim-sulfamethoxazoleTreatment groupsPotassium concentrationControl groupCommunity-based teaching hospitalDevelopment of hyperkalemiaDays of therapyProspective chart reviewConcurrent renal insufficiencyRenal insufficiencyChart reviewSevere hyperkalemiaHospitalized patientsSerum sodiumTeaching hospitalAnion gapPatients
1994
Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results.
Kaminski N, Bogomolski V, Stalnikowicz R. Acute bacterial diarrhoea in the emergency room: therapeutic implications of stool culture results. Emergency Medicine Journal 1994, 11: 168. PMID: 7804582, PMCID: PMC1342424, DOI: 10.1136/emj.11.3.168.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAdolescentAdultAgedAged, 80 and overAmpicillinBacterial InfectionsBacteriological TechniquesChildChild, PreschoolCiprofloxacinDiarrheaDrug Resistance, MicrobialDysentery, BacillaryEmergency Service, HospitalEscherichia coli InfectionsFecesHumansInfantMicrobial Sensitivity TestsMiddle AgedSalmonella InfectionsTrimethoprim, Sulfamethoxazole Drug CombinationConceptsTrimethoprim-sulfamethoxazoleEmergency roomStool culture resultsTreatment of choiceAcute diarrhoeal diseaseAcute bacterial diarrheaEmergence of resistanceEmpiric treatmentAcute diarrheaStool culturesShigella isolatesBacterial diarrheaNew quinolonesSick patientsTherapeutic implicationsDiarrhoeal diseaseCulture resultsDrug resistanceShigella speciesPatientsStudy periodShigella sonneiAntimicrobial resistanceAntimicrobial drugsDiarrhea
1993
Immune-Based Therapeutics: Scientific Rationale and the Promising Approaches to the Treatment of the Human Immunodeficiency Virus-Infected Individual
Stein D, Timpone J, Gradon J, Kagan J, Schnittman S. Immune-Based Therapeutics: Scientific Rationale and the Promising Approaches to the Treatment of the Human Immunodeficiency Virus-Infected Individual. Clinical Infectious Diseases 1993, 17: 749-771. PMID: 8268360, DOI: 10.1093/clinids/17.4.749.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHuman immunodeficiency virus infectionHIV infectionHuman immunodeficiency virus-infected individualsImmunopathogenesis of HIV infectionHIV-associated Kaposi's sarcomaAdoptive cellular immunityVirus-infected individualsModality of treatmentApproaches to therapyAntiretroviral agentsTherapeutic vaccinesTrimethoprim-sulfamethoxazoleImmunodeficiency virusImmune deficitsImmunomodulatory interventionsImmunological dysfunctionClinical benefitImmunomodulatory approachesPrimary approach to therapyKaposi's sarcomaImmunomodulatory agentsCellular immunityPooled immunoglobulinClinical data
1985
The Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome
Small C, Harris C, Friedland G, Klein R. The Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome. JAMA Internal Medicine 1985, 145: 837-840. PMID: 3873229, DOI: 10.1001/archinte.1985.00360050081015.Peer-Reviewed Original ResearchConceptsPneumocystis carinii pneumoniaImmunodeficiency syndromeAdverse reactionsCarinii pneumoniaEpisodes of PCPRecurrent Pneumocystis carinii pneumoniaAcquired Immunodeficiency SyndromeUnresponsive infectionsLate recurrenceTrimethoprim-sulfamethoxazolePatientsAdditional episodesSyndromeTherapySecond weekPneumoniaEpisodesImmediate reactionsFailure rateLeukopeniaRashFeverRecurrenceHepatotoxicityInfection
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply